B-Secur
B-Secur is a Belfast-based medical technology company that licenses FDA-cleared HeartKey ECG and bioimpedance algorithms and SaaS to consumer wearable, medical device, and hospital system customers for medical-grade cardiac monitoring integration.
- Company typePrivate
- Founded2016
- HeadquartersBelfast, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What B-Secur does
B-Secur Limited is a Belfast, Northern Ireland-based medical technology company that develops FDA 510(k)-cleared ECG and bioimpedance signal-processing software for integration into third-party devices. The company's core product, the HeartKey algorithm suite, processes cardiac signals captured from either dry or wet electrodes and supports spot-check or continuous monitoring, deployable on-device or in the cloud, with a 2024 FDA-cleared HeartKey Rhythm addition for proactive cardiac care. Underlying capabilities include proprietary ECG signal denoising, dry-electrode signal conditioning, signal quality assessment, and bioimpedance analysis, backed by a clinical validation corpus of more than 2 million hours of data and over 7 billion heartbeats analyzed, and supported by an internal preclinical testing facility called ABEL (Advanced Biosensing Engineering Lab).
The company operates a B2B technology-licensing and SaaS model. Revenue is generated through licensing HeartKey algorithms to consumer wearable manufacturers (smartwatches, rings, patches, clothing-integrated devices), medical device OEMs (ambulatory monitors, Holter devices, patches), and hospital systems for remote patient monitoring, supplemented by cloud-based SaaS deployments, professional services covering regulatory and clinical strategy, and ECG hardware design support. Distribution is direct enterprise sales with technical conversations between engineers as the entry point, complemented by a semiconductor partner ecosystem (STMicroelectronics, Texas Instruments, NXP, Analog Devices) that positions HeartKey within OEM reference designs.
B-Secur is venture-backed, having raised approximately $27.4 million across multiple rounds between 2015 and 2023 from investors including Kernel Capital, Accelerated Digital Ventures (ADV), Wharton Asset Management, First Capital Ventures, Co-FundNI, and the British Business Bank's Future Fund. The company employs roughly 100 people across offices in the United Kingdom, Ireland, and the United States, with a Country Manager presence in India, and holds ISO 13485:2016 certification (TÜV SÜD) in addition to its FDA clearances. Named commercial partners and customers include WHOOP, Biotricity, Sensr, Orlando Health, FIRMINIQ, SweatWorks, and Galen Data.
B-Secur firmographics
Firmographics- Name
- B-Secur
- Legal name
- B-Secur Limited
- Website
- https://b-secur.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- B-Secur is a Belfast-based medical technology company that licenses FDA-cleared HeartKey ECG and bioimpedance algorithms and SaaS to consumer wearable, medical device, and hospital system customers for medical-grade cardiac monitoring integration.
- Ownership category
- akta.pro rank
B-Secur industry classification
Industry- Product category
- Cardiac Monitoring Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC), Cardiology Telemedicine Platforms (HLALAGAB)
Keywords
Where B-Secur is headquartered
LocationHeadquarters
- HQ city
- Belfast
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
B-Secur business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Technology Licensing: Licenses FDA-cleared ECG algorithms and biosensing technology to device manufacturers for integration into consumer wearables, medical devices, and other products.
- Software-as-a-Service (SaaS): Cloud-based ECG analysis solutions deployed as SaaS for customers requiring cloud processing rather than on-device deployment.
- Professional Services: Regulatory strategy, preclinical testing support, and Quality Management Systems guidance for device manufacturers navigating FDA and regulatory submission processes.
- Hardware Partnership Services: Electrode design, materials selection, ECG electronic schematic, PCB design, mechanical design, and test strategy services for hardware partners.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
B-Secur product offering
Product offeringCore offering
B-Secur develops and licenses the FDA 510(k)-cleared HeartKey algorithm suite for ECG and bioimpedance signal processing, targeting device manufacturers across consumer wearables, medical devices, and hospital systems. The company also provides supporting services including dry electrode hardware design, preclinical validation through ABEL (Advanced Biosensing Engineering Lab), and regulatory strategy support for FDA and quality management system submissions. Deployment options include on-device or cloud-based processing for both dry and wet electrode configurations.
Product overview
B-Secur is a B2B medical software (SaaS) company offering end-to-end ECG and bioimpedance solutions for biosensing in consumer wearables, medical devices, and clinical applications. The core product is HeartKey®, an FDA 510(k)-cleared algorithm suite providing cardiac rhythm analysis, augmented by hardware design services, preclinical validation through ABEL (Advanced Biosensing Engineering Lab), and regulatory strategy support. The company positions itself as a partner for device manufacturers, offering plug-in solutions at any stage from signal capture to validated algorithms, deployable on-device or cloud-based.
Differentiator
Problem solved
Functional benefit
Brands
- HeartKey: FDA-cleared ECG algorithm suite for dry or wet electrodes, spot-check or continuous monitoring, and on-device or cloud deployment.
Products and services
- HeartKey FDA 510(k)-cleared algorithm suite for ECG analysis supporting dry or wet electrodes, spot-check or continuous monitoring, and on-device or cloud deployment for cardiac rhythm detection; licensed to device manufacturers for integration into their products.
- HeartKey Rhythm FDA-cleared cardiac rhythm monitoring solution providing proactive and efficient cardiac care with enhanced rhythm analysis capabilities for device manufacturers.
- HeartKey 2.0 Next-generation EKG algorithm suite providing breakthrough medical accuracy through enhanced signal clarity and noise reduction, with FDA-cleared health data and actionable wellness insights.
- ABEL (Advanced Biosensing Engineering Lab) Pressure-testing service for the sensing stack providing bench testing and preclinical validation to uncover ECG program limitations with evidence-based guidance for device manufacturers.
- ECG Hardware Design Services Hardware expertise partnership covering electrode design, materials selection, ECG electronic schematic, PCB design, mechanical design, and test strategy for ECG and bioimpedance signal capture.
- Regulatory & Clinical Strategy Services Preclinical study design, Quality Management Systems, and 510(k) strategy support services to help device manufacturers turn prototypes into market-ready medical products.
Quantifiable outcome
- 98.3% sensitivity and 100% specificity for AF detection from 30-second wrist ECGs
- +3 more outcomes
Companies that use B-Secur
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
B-Secur technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature7 records
B-Secur partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Orlando HealthcoreClinical wearable pilot program partnership with Orlando Health through its Orlando Health Ventures arm. B-Secur contributes ECG software technology to WHOOP wristbands used for monitoring COPD patients post-discharge at Orlando Health South Lake Hospital, aiming to improve patient care and reduce readmissions.
- WHOOPcoreIntegration of B-Secur's FDA-cleared ECG software technology into WHOOP wristbands as part of the Orlando Health clinical pilot program. WHOOP devices measure up to 50 metrics including clinical-grade ECGs.
- SensrcorePartner in the Orlando Health clinical wearable pilot program, providing monitoring infrastructure and data management capabilities.
- FIRMINIQminorStrategic partnership to transform cardiovascular health management through combined expertise in cardiac monitoring solutions.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
B-Secur competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
B-Secur social profiles
Digital presenceB-Secur compliance and trust
Trust signalCompliance2 records
B-Secur financial estimates
Financial estimateRevenue estimate
Valuation estimate
B-Secur leadership team
Management profileNumber of profiles
Profiles15 records
B-Secur funding detail
Funding detailFunding overview
Funding rounds7 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
B-Secur M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about B-Secur
What does B-Secur do?
B-Secur develops and licenses the FDA 510(k)-cleared HeartKey algorithm suite for ECG and bioimpedance signal processing, targeting device manufacturers across consumer wearables, medical devices, and hospital systems. The company also provides supporting services including dry electrode hardware design, preclinical validation through ABEL (Advanced Biosensing Engineering Lab), and regulatory strategy support for FDA and quality management system submissions. Deployment options include on-device or cloud-based processing for both dry and wet electrode configurations.
Is B-Secur a public or private company?
B-Secur is a private company. It is classified as venture growth investor backed and is currently operating.
When was B-Secur founded?
B-Secur was founded in 2016. It employs 51 to 100 people.
Where is B-Secur based?
B-Secur is headquartered in Belfast, United Kingdom, in the Europe region.
How does B-Secur make money?
Four revenue lines are on record. Technology Licensing is the primary driver. The others are software-as-a-Service (SaaS), professional Services and hardware Partnership Services.
Does B-Secur have an API?
No public API is recorded for B-Secur.
What industry is B-Secur in?
B-Secur's product category is Cardiac Monitoring Software. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of CRACAQAC, ECG/EKG & Heart Rhythm Monitors (Consumer). Its NAICS code is 334510 and its SIC code is 3845.